E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/26/2006 in the Prospect News Biotech Daily.

Align Technology price target upped by JMP

JMP Securities analyst Anthony Ostrea reiterated Align Technology, Inc. at market outperform and raised the price target to $18, from $14, on news of the company's third-quarter 2006 results "non-event." Ostrea estimated $192.6 million and $233.5 million in U.S. revenue in 2007 and 2008, with minimal residual costs from OrthoClear litigation in 2007. The analyst also raised 2007 GAAP earnings per share estimate to $0.15, from $0.07. Shares of the Santa Clara, Calif., dental technology company were up 16 cents, or 1.13%, at $14.38. (Nasdaq: ALGN)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.